EDUCATION, RESEARCH
Jun 26, 2019

Request for postdoctoral applications on the T32 Hematology Training Grant

We are pleased to announce a request for postdoctoral applications on the T32 Hematology Training Grant. The application deadline is July 15, 2019. The application details are enclosed. Please contact Betty Leibold for project eligibility and questions regarding the Hematology Program betty.leibold@genetics.utah.edu... Read More

Hematology Research Symposium at Deer Valley
EDUCATION
May 10, 2019

Hematology Research Symposium at Deer Valley

The Hematology Research Symposium on June7-8, 2019 will feature a host of internal and external experts promoting the many strengths of hematologic research including lymphoid and myeloid malignancies, immunotherapy, genomics in hematologic malignancies, and more. ... Read More

RESEARCH
May 07, 2019

Can You Survive If You Run Out of Air?

The human body can only survive a few minutes with oxygen – or can it? Read the amazing story of a diver who survived with no oxygen on the ocean floor, and the research behind the seemingly impossible. Featuring research from Melissa Ilardo, PhD, Post-Doctoral Fellow. ... Read More

EDUCATION
Apr 19, 2019

Utah Amyloidosis Program Overview

Since 2015, the multidisciplinary Utah Amyloidosis Program has focused on improving care for patients with amyloidosis—a rare but serious protein deposition condition affecting multiple body systems.... Read More

Congratulations
RECOGNITION
Apr 10, 2019

Congratulations

Congratulations to three Division members who were awarded P&F funding from the Center of Excellence in Hematological Malignancies and Hematology.... Read More

Congratulations to Dr. Ami Patel for her selection in the VPCAT Research Scholars Program
RECOGNITION
Nov 27, 2018

Congratulations to Dr. Ami Patel for her selection in the VPCAT Research Scholars Program

Congratulations to Dr. Ami Patel for her selection in the VPCAT Research Scholars Program at the University of Utah. This is a two-year program providing scholars with mentoring and leadership training and research resources. Selected scholars have access to biostatisticians in the Center for Clinical & Translational Science (CCTS) and grant submission specialists. These resources facilitate appropriate study design, collection of pilot data and the preparation and submission of competitive grant applications.... Read More

Welcome Dr. Ming Lim
RECOGNITION
Nov 01, 2018

Welcome Dr. Ming Lim

Dr. Ming Lim is joining the Hematology/Hematologic Malignancies department specializing in non-malignant hematology. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her main interests lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting patients with congenital bleeding disorders, specifically hemophilia patients with inhibitors. Previously, Dr. Lim was Assistant Professor of Medicine in the Division of Hematology/Oncology at the Medical University of South Carolina from 2015-2018. There she also served as the Associate Program Director for the MUSC Hematology/Oncology Fellowship Program. Dr. Lim is actively involved in the American Society of Hematology (ASH) and the Hemostasis and Thrombosis Research Society (HTRS). She serves as the Co-Chair for the HTRS Junior Faculty Network and is a committee member for the HTRS Trainee Workshop.... Read More

Celebrating Advanced Practice Clinicians
RECOGNITION
Oct 23, 2018

Celebrating Advanced Practice Clinicians

Natalie Turner, AGACNP (Hematology) is one of many great APCs working for The Department of Internal Medicine. We are recognizing them for the exceptional care they provide to our patients.... Read More

Congratulations Dr. Dennis Winge
RECOGNITION, RESEARCH
Oct 01, 2018

Congratulations Dr. Dennis Winge

Congratulations to Dr. Dennis Winge who was awarded a R01 Competitive Renewal Grant from the NIH National Institute of General Medical Sciences.... Read More

HemOnc Today honors Next Gen Innovators at ASCO
RECOGNITION
Sep 25, 2018

HemOnc Today honors Next Gen Innovators at ASCO

Congratulations Deborah M. Stephens, DO (Hematology), Ignacio Garrido-Laguna, MD, and Ben Maughan, MD (Oncology) on being recognized as Next Gen Innovators, which is an initiative that helps showcase the talents and expertise of rising stars in hematology and oncology. Read More.... Read More

Welcome Dr. Boyu Hu
RECOGNITION
Sep 01, 2018

Welcome Dr. Boyu Hu

Dr. Boyu Hu is joining the Hematology/Hematologic Malignancies department specializing in lymphoma, chronic lymphocytic leukemia and lymphoma genetics and prognostication. ... Read More

Hematology Research Symposium at Deer Valley
EDUCATION
May 22, 2018

Hematology Research Symposium at Deer Valley

The Hematology Research Symposium on June 8-9, 2018 will feature a host of internal and external experts promoting the many strengths of hematologic research including lymphoid and myeloid malignancies, immunotherapy, genomics in hematologic malignancies, and more. ... Read More

Dr. Paul Bray Recipient of NIH Grant
RESEARCH
Apr 20, 2018

Dr. Paul Bray Recipient of NIH Grant

Congratulations to Dr. Paul Bray for his award of a NIH grant from the National Heart, Lung, and Blood Institute. The grant awarded from 2018 through 2022 is focused on in vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activation. The goal of Dr. Bray’s studies is to glean insights into the molecular genetic mechanisms that contribute to blood platelet formation and function. Dr. Bray and his team will investigate the role of microRNA regulation of megakaryocyte gene expression and test the hypothesis that specific microRNAs modulate the development of megakaryocytes into platelets and platelet function. One additional aspect of their studies will be testing whether microRNAs can enhance the in vitro production of platelets as a potential therapeutic for thrombocytopenia and thrombocytosis.... Read More

EDUCATION
Apr 02, 2018

Alternative Transportation Incentive Program

Nearly a year ago, Dr. Deininger and the Division of Hematology Administration announced a Division Commuter Incentive Program to encourage faculty and staff to take alternative modes of transportation to work apart from vehicle driving. The goals were to promote employee health and make our contribution to lowering our carbon footprint. Seventeen Division employees completed the survey to participate and in the course of this past year, the group of participants amassed a grand total of 22,496 miles of alternative commuting (UTA bus/train, walking & cycling). Included in the Incentive Program was a drawing held monthly to select monthly commuter winners and three grand prize awardees who amassed the most number of trips over the year. The number of monthly commuter trips has held quite constant during the past year among participants. The goal is now to expand the number of participants and to model this to a larger Health Sciences Program. ... Read More

CAR T-Cell Lymphoma Trial Underway
RESEARCH
Apr 02, 2018

CAR T-Cell Lymphoma Trial Underway

The University of Utah and Huntsman Cancer Institute were just selected as one of the few national cancer centers for a large Novartis and KITE Pharma Inc.-sponsored anti-CD19 CAR T-cell immunotherapy clinical trial focused on relapsed or refractory diffuse large B-cell lymphoma, a form of non-Hodgkin lymphoma. Our Cell Therapy and Regenerative Medicine Program (CTRM) Center will be a key component of this clinical trial. The FDA requires special certification for sites offering CAR T-cell therapy, and only specially trained hospitals and clinics are part of the network of treatment centers.This is an exciting new immunotherapy option for lymphoma patients.... Read More

HCI Joins Study Aimed at Improving Leukemia Screening, Treatment
RESEARCH
Mar 28, 2018

HCI Joins Study Aimed at Improving Leukemia Screening, Treatment

A new clinical trial for patients with acute myeloid leukemia will open at the Huntsman Cancer Institute. This trial consisting of eight academic centers will conduct a quick molecular genetic test to guide physicians in the appropriate treatment. This personalized treatment protocol should enhance the effectiveness in AML therapy. The trial seeks to enroll 500 subjects and is estimated to be completed in 2021. Dr. Mike Deininger, Dr. Tibor Kovacsovics and Dr. Paul Shami will lead the clinical trial at the Huntsman Cancer Institute.... Read More

3rd Annual HCI Immunotherapy Conference
EDUCATION, RESEARCH
Mar 28, 2018

3rd Annual HCI Immunotherapy Conference

The third annual Huntsman Cancer Institute Cancer Immunotherapy Conference will be held on April 27, 2018 in the J. Willard and Alice S. Marriott Foundation Auditorium in the HCI Research South Building starting at 7:45 AM. The conference will include basic scientists and clinicians with an interest in immunotheraphies for cancer treatment. Among the speakers are Kevin Hay, MD; Annette Künkele, MD; Chris DeRenzo, MD, MBA; and Yong-Chen William Lu, Ph.D.... Read More

Congratulations Dr. Luetkens
RESEARCH, RECOGNITION
Mar 20, 2018

Congratulations Dr. Luetkens

The National Comprehensive Cancer Network (NCCN) Foundation announced Dr. Tim Luetkens in the Division of Hematology and Hematologic Malignancies as a recipient of the 2018 Young Investigator Awards. The NCCN Foundation selects 4 young investigators at the forefront of their field each year to support their career development. These highly qualified researchers are noted for their innovative ideas in improving the quality, effectiveness, and efficiency of care provided to cancer patients. Dr. Luetkens’ innovative research in the laboratory of Professor Djordje Atanackovic focuses on CD229 CAR T cell immunotherapy in Multiple Myeloma. Dr. Luetkens will be awarded $150,000 over a two-year period to support his innovative work.... Read More

Congratulations Dr. Shami
RECOGNITION
Mar 12, 2018

Congratulations Dr. Shami

Congratulations to Dr. Paul Shami on his appointment as Research Compliance Office Medical Director. Dr. Shami will also chair the Data and Safety Monitoring Committee and will provide leadership to the Research Compliance Office in ensuring safe, ethical, and responsible conduct of clinical research at HCI.... Read More

RESEARCH, EDUCATION, RECOGNITION
Dec 08, 2017

Pilot Awards

The Division of Hematology and Hematologic Malignancies awarded pilot research grants of $40,000 to four faculty. We congratulate Drs. Paul Bray, Tim Luetkens, Doug Sborov and Mike Deininger for their selections as awardees. ... Read More

Hematology Division Faculty Hike
RECOGNITION
Oct 25, 2017

Hematology Division Faculty Hike

The Hematology Division enjoyed a group hike up to Dog Lake in the Wasatch Mountains on September 26. A recent snowfall resulted in a beautiful hike on a snow packed trail. ... Read More

Congratulations Drs. Deininger & O'Hare
RECOGNITION, RESEARCH
Oct 05, 2017

Congratulations Drs. Deininger & O'Hare

Congratulations to Drs. Mike Deininger and Thomas O'Hare for their receipt of a three year V Foundation Translational Grant award on Targeting SIRT5 in Acute Myeloid Leukemia. The V Foundation for Cancer Research was founded by legendary basketball coach Jim Valvano with the goal of achieving victory over cancer through research.... Read More

Congratulations Dr. Shami
RESEARCH
Sep 25, 2017

Congratulations Dr. Shami

Dr. Paul Shami and JSK Therapeutics were granted an award from the Small Business Innovation Research Program of the National Cancer Institute to conduct IND-enabling studies of their nitric oxide-generating drug JS-K. JS-K has shown efficacy in animal models of acute myeloid leukemia, multiple myeloma, non-small cell lung cancer and several other solid tumors. Completion of work conducted with this award will allow initiation of Phase I clinical trials of this first-in-class anti-cancer agent. Congratulations to Dr. Shami and his team for this Direct-to-Phase II SBIR award. ... Read More

RESEARCH, EDUCATION
Sep 01, 2017

2017 Multiple Myeloma Symposium

The 2017 Multiple Myeloma Symposium will be held at the Huntsman Cancer Institute on Saturday October 14, 2017 from 8:45 AM to 4 PM. Attendance is free, but registration is required. This symposium will provide an overview of recent developments in therapeutic approaches to myeloma. The program consists of local myeloma experts along with outside authorities. Dr. Adam Cohen from the University of Pennsylvania and Dr. Yi Lin from the Mayo Clinic are featured guest speakers and will address CAR T cell therapies.... Read More

Congratulations Dr. Josef Prchal
RECOGNITION
Aug 02, 2017

Congratulations Dr. Josef Prchal

Congratulations to Dr. Josef Prchal on his selection by the American Society of Hematology for the prestigious 2017 Henry M. Stratton Medal. This award honors elite researchers in hematology research and Dr. Prchal has distinguished himself with his research into a range of disorders of erythrocytes including primary and secondary polycythemias. Dr. Prchal’s many innovations in the field include the description of the von Hippel-Lindau (VHL) mutation in recessive Chuvash familial polycythemia and elaboration on the pathobiology of erythropoietin receptor (EPOR) mutations in autosomal dominant familial polycythemia. His genetic investigations of acquired polycythemia vera led to the association of chromosome 9p abnormalities – where the JAK2 gene is located – with the disease. More recently, Dr. Prchal and his collaborators showed that Tibetans are protected from high altitude polycythemia as a result of a high altitude genetic adaptation due to variants of the EGLN1 and EPAS1 genes.... Read More

Congratulations Sabari
RECOGNITION
Jun 20, 2017

Congratulations Sabari

Congratulations to Dr. Sabari Radhakrishnan who was awarded a two year American Association for Cancer Research-Pfizer Immuno-Oncology Fellowship. This fellowship was established in 1996 and provides funding to promising young investigators who have strong potential to become productive and successful independent cancer research scientists. Dr. Radhakrishnan's research focuses on chimeric antigen receptor (CAR) T cell therapy for multiple myeloma. He has generated multiple CAR T cells targeting a multiple myeloma surface antigen and is testing the efficacy of his CAR T cells in a mouse multiple myeloma model system. ... Read More

Congratulations Ami
RECOGNITION
Jun 14, 2017

Congratulations Ami

Congratulations to Dr. Ami Patel who was selected for an ASH training scholarship by the Study Section for the American Society of Hematology's Research Training Award for Fellows (RTAF). ... Read More

EDUCATION, RESEARCH
Mar 03, 2017

2nd Annual Cancer Immunotherapy Conference

The University of Utah School of Medicine is sponsoring a one-day conference on March 25, 2017 on cancer immunotherapy that will bring together basic researchers and clinicians with an interest in immunotherapies as promising approaches for patients with different types of cancer. The conference will provide an update on the most recent developments in the field of cancer immunotherapy and it will facilitate collaborative efforts between basic tumor immunologists and oncologists/hematologists using novel immunotherapeutic approaches to the benefit of their patients. This conference will help us to identify the most promising immunotherapies for our patients leading to improved outcomes and maybe even cures.... Read More

7th Annual Hematology Review
EDUCATION, RESEARCH
Jan 10, 2017

7th Annual Hematology Review

The Seventh Annual Hematology Review conference will take place February 11, 2017 at the Huntsman Cancer Institute, and will feature keynote speaker Jerald Radich, MD, of the Fred Hutchinson Cancer Research Center.... Read More

7th Annual Hematology Review
EDUCATION, RESEARCH
Jan 10, 2017

7th Annual Hematology Review

The Seventh Annual Hematology Review conference will take place February 11, 2017 at the Huntsman Cancer Institute, and will feature keynote speaker Jerald Radich, MD, of the Fred Hutchinson Cancer Research Center.... Read More

RECOGNITION, RESEARCH
Dec 14, 2016

Congratulations to 2016 ASH Junior Presenters

Congratulations to Hematology faculty and trainees who had delivered presentations at the December 2016 ASH meeting in San Diego CA. Drs. Halwani and Stephens presented their clinical trials research on lymphoma. Clinical Fellow Dr. Ami Patel presented a lecture entitled, "Oral-34: Stroma-Based Activation of pSTAT3Y705 Confers Resistance to FLT3 Inhibitors in FLT3 ITD-Positive AML". Two post-doctoral fellows in the laboratory of Drs. Deininger and O'Hare Dr. Anna Eiring and Dr. Dongqing Yan delivered presentations entitled, " Oral-34: Stroma-Based Activation of pSTAT3Y705 Confers Resistance to FLT3 Inhibitors in FLT3 ITD-Positive AML" and " Oral-636: Selective Inhibition of Nuclear Cytoplasmic Transport As a New Treatment Paradigm in Myelofibrosis", respectively. ... Read More

RECOGNITION, RESEARCH
Nov 22, 2016

Congratulations to Dr. Djordje Atanackovic

Congratulations to Dr. Atanackovic for his receipt of the 2017 Brian Novis Senior Science award from the International Myeloma Foundation. His research focuses on immunotherapeutic approaches for multiple myeloma. ... Read More

RESEARCH
Nov 07, 2016

Welcome to Dr. Paul Bray

We are pleased to welcome Dr. Paul Bray to the faculty in the Division of Hematology and Hematologic Malignancies. He received his MD degree from the University of Utah in 1977, where he did research with Drs. George Cartwright and Corwin Edwards on hemochromatosis. He did his Internal Medicine Residency at Baylor College of Medicine in Houston, Texas, followed by a Hematology/Oncology Fellowship at the University of California in San Francisco (UCSF). He was on the Hematology faculty at Johns Hopkins University School of Medicine from 1990-2000 and served as Medical Director of the Special Coagulation Laboratory. In 2000 was recruited to Baylor College of Medicine as the first Chief of a new Section of Thrombosis Research, where he developed a world-class program. Dr. Bray was subsequently recruited to the Jefferson Medical College as the 6th Director of the Cardeza Foundation for Hematologic Research and Director of Hematology. He also served as the Director of the Cardeza Special Hemostasis Laboratory and the Associate Vice Chair of Research for the Department of Medicine. He has served in numerous national and international advisory positions, NIH review panels and committees for the American Society of Hematology and the International Society of Thrombosis and Haemostasis (ISTH). He is a charter member and co-Chair of the ISTH Scientific Subcommittee Genomics in Thrombosis and Hemostasis. He has an extensive track-record of educational successes, having trained more than 25 postdoctoral fellows, graduate students, Hem/Onc fellows and junior faculty. He has given scores of national and international invited lectures. Dr. Bray has had 30 years of continuous funding from the National Institutes of Health (NIH) and currently is PI on three NIH R01 grants. Dr. Bray’s laboratory performs basic and translational research on 1) the role of platelets in inherited and acquired disorders of hemostasis, thrombosis and cardiovascular disease, 2) genomic and transcriptomic approaches to identification of novel genes and gene variants involved in platelet reactivity and pharmacogenetics, and 3) the role of platelet microRNAs (and other non-coding RNAs) on platelet gene expression and physiology, and 4) the molecular mechanisms by which these genes and transcripts regulate platelet thrombus formation. He has published more than 160 peer-reviewed papers, book chapters and invited reviews. Dr. Bray is a clinical Hematologist who cares for out-patients with non-malignant hematology disorders. We welcome Dr. Bray to our faculty.... Read More

RESEARCH
Oct 19, 2016

Pilot and Feasibility Grant Awards

Our NIDDK-funded Center for Iron and Hematology Disorders has awarded three pilot research grants for the 2016/2017 fiscal year. Six proposals were considered for funding and the three successful applicants include the following:... Read More

RESEARCH
Oct 10, 2016

Welcome to Dr. Vedran Radojcic

We are pleased to welcome Dr. Vedran Radojcic to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Radojcic was born and raised in Croatia where he completed his medical training. After completing internship in the Bone Marrow Transplantation Unit and a research fellowship at University of Zagreb, he joined the Johns Hopkins University School of Medicine as a postdoctoral fellow, focusing on immunology of blood and marrow transplantation. He subsequently relocated to the University of Michigan where he completed internship and residency in Internal Medicine as the "Most Outstanding House Officer". Upon completion of his residency, he accepted a fellowship in Hematology/Oncology at the University of Michigan and was awarded the Mark Roth Memorial Award in the Division of Hematology/Oncology. His research as a fellow was sponsored through the T32 training grant, American Society of Hematology Research Training award for Fellows, and Robert A. Good New Investigator Award by the American Society of Blood and Marrow Transplantation. His research is focused on immunobiology of graft-versus-host disease and was instrumental in identifying Notch signaling in T cells as a therapeutic target for preventingchronic graft-versus-host disease. Dr. Radojcic will join the Bone Marrow Transplantation program at the Huntsman Cancer Institute and establish a laboratory-focused research program in transplant immunology. We welcome Dr. Radojcic to our faculty.... Read More

RESEARCH
Sep 01, 2016

Welcome to Dr. Doug Sborov

We are pleased to welcome Dr. Douglas Sborov to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Sborov was born and raised in Minneapolis, MN, graduated from the University of Wisconsin-Madison with his Bachelors of Science, and completed his medical training at The American University of the Caribbean School of Medicine. Following medical school, he completed his Internal Medicine Residency at the University of Utah, and later his Hematology, Oncology, and Bone Marrow Transplant Fellowship at The Ohio State University. During this time, he obtained his Masters in Medical Science with a concentration in tumor immunology, and completed the National Institutes of Health (NIH) funded T32 training grant with a focus in clinical research and trial development. Over the course of his training, Dr. Sborov developed a passionate interest in the development of novel therapeutics for the treatment of patients with multiple myeloma, as well treating patients undergoing bone marrow transplantation. Dr. Sborov will join the myeloma program at the Huntsman Cancer Institute. We welcome Dr. Sborov to our faculty.... Read More

Multiple Myeloma Symposium
EDUCATION, RESEARCH
Aug 22, 2016

Multiple Myeloma Symposium

The Division of Hematology and Hematologic Malignancies at the University of Utah is sponsoring an inaugural Multiple Myeloma Symposium to be held September 10, 2016 at the Huntsman Cancer Institute. The symposium will provide an overview of the most recent developments in the field of myeloma therapy. The keynote speaker this year is Dr. Frits van Rhee from the University of Arkansas for Medical Sciences, Myeloma Institute. Dr. Frits van Rhee will discuss Novel Treatments in Multiple Myeloma.... Read More

Thanks to Dr. Lewis Cantley!
RESEARCH
Aug 10, 2016

Thanks to Dr. Lewis Cantley!

Dr. Lewis Cantley, Professor of Cancer Biology in Medicine at the Sandra and Edward Meyer Cancer Center at the Weill Cornell Medical College delivered the 2016 George E. Cartwright Memorial Endowed Lecture August 4, 2016. Dr. Cantley presented his research on the signaling pathway of the PI3K kinase and its role in oncogenesis. Dr. Cantley is a highly distinguished scientist and a member of the National Academy of Sciences and the Institute of Medicine of the National Academies.... Read More

RESEARCH, EDUCATION
Aug 01, 2016

Congratulations to Dr. Chuck Parker

Congratulations to Dr. Chuck Parker for his selection by the American Society of Hematology to serve on the Awards Committee for the Society for a four year term. Dr. Parker will also Chair a session at the 2016 annual ASH meeting in the Educational Program. ... Read More

RESEARCH, RECOGNITION
Jul 13, 2016

Congratulations to Dr. Betty Leibold

Congratulations to Dr. Betty Leibold who was awarded a competitive RO1 research grant from the National Institutes of Health, NIDDK Institute. Dr. Leibold's research grant builds on her discovery that the processing of proinsulin is impaired in mice lacking the iron regulatory protein 2 (IRP2). The irp2 -/- mice exhibit elevated proinsulin levels and reduced pancreatic insulin secretion. She seeks to elucidate the mechanism by which IRP2 contributes to proinsulin processing.... Read More

RESEARCH, EDUCATION
Jul 12, 2016

Hematology Huntsman 5K Walk

The annual Hematology Huntsman Disease-Oriented Team 5K Walk is scheduled for Saturday October 15, 2016. The walk/run will start at the Fort Douglas bandstand. Faculty, family, patients and friends are welcome.... Read More

EDUCATION, RESEARCH, RECOGNITION
Jul 12, 2016

Congratulations Dr. Deborah Stephens

Congratulations to Dr. Deborah Stephens on her recently accepted manuscript in the Journal of Clinical Oncology. The study entitled, " Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736" reported on a two decade follow up by the SWOG Lymphoma Working Group on risk assessment of 400 patients with diffuse large B-cell lymphoma. The group reported that relapse occurred independent of the treatment modality. This highlights the importance of long-term followup studies to assess treatment efficacy.... Read More

EDUCATION, RESEARCH
May 10, 2016

Congratulations to Dr. Catherine Lee

Congratulations to Catherine Lee, Assistant Professor of Medicine, Hematology/Hematologic Malignancies and Blood and Marrow Transplantation (BMT) for being accepted to the 2016 American Society for Blood and Marrow Transplantation (ASBMT) Clinical Research Training Course. Selection into this course is highly competitive and based upon the merits of the candidate, mentor, and the submitted research project proposal. Catherine is one of 12 fellows and junior faculty members who will have the opportunity to deepen their knowledge of clinical and clinical-translational research design by working with senior mentors in blood and marrow transplantation. We look forward to hearing about her experience. Congratulations again!... Read More

EDUCATION, RESEARCH
Feb 05, 2016

6th Annual Hematology Review

The Sixth Annual Hematology Review will take place Saturday, February 13th at the Huntsman Cancer Institute. This one-day conference provides an update on the treatment of malignant and benign hematologic diseases. The keynote speaker is Dr. Jerald Radich who is Professor of Medical Oncology at the University of Washington School of Medicine. Dr. Radich specializes in the molecular genetics of leukemia and the detection of minimal residue disease. The additional speakers at the conference are faculty members of the Division of Hematology at the University of Utah. Registration is freely available at: hematology.conference@hsc.utah.edu.... Read More

RESEARCH
Feb 04, 2016

Congratulations to Dr. Ahmad Halwani

Dr. Ahmad Halwani has been selected as a University of Utah Vice President's Clinical and Translational (VPCAT) Research Scholar for the 2016-2017 year. This award supports junior faculty in the University of Utah Health Sciences who are committed to research careers. This is a competitive mentored program to provide leadership competencies and develop the essential research knowledge and practical skills to be an effective clinical or translational researcher. We congratulate Dr. Halwani on his selection as a VPCAT Scholar.... Read More

Welcome Dr. Srinivas (Sri) Tantravahi to the Faculty - U of U School of Medicine
RECOGNITION
Dec 10, 2015

Welcome Dr. Srinivas (Sri) Tantravahi to the Faculty

We are pleased to welcome Dr. Srinivas (Sri) Tantravahi to the faculty in the Division of Hematology and Hematologic Malignancies as a Clinical Instructor. Sri completed his medical school education in the Guntur Medical College in India and subsequently completed a residency in Internal Medicine at the Sheffield Teaching Hospitals in the United Kingdom and obtained membership in the Royal College of Physicians.... Read More

Welcome Dr. Catherine Lee to the Faculty - U of U School of Medicine
RECOGNITION
Nov 06, 2015

Welcome Dr. Catherine Lee to the Faculty

Dr. Lee recently completed a fellowship in blood and marrow transplantation at Stanford University. She received her MD degree at New York University School of Medicine. She completed a fellowship in oncologic palliative care and pain medicine at Memorial Sloan-Kettering Cancer Center and a second fellowship in hematology/oncology at the University of Pittsburgh Cancer Institute. ... Read More

Welcome Dr. Daniel Couriel to the Faculty - U of U School of Medicine
RECOGNITION
Sep 11, 2015

Welcome Dr. Daniel Couriel to the Faculty

We are pleased to welcome Dr. Daniel Couriel to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Couriel, MD, MS, is the new director of the Bone Marrow Transplant Program.... Read More

RECOGNITION
Jun 11, 2015

Welcome Dr. Axel Zander to the Faculty

We are pleased to welcome Dr. Axel Zander to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Zander will assume the Interim Directorship of the HCI Bone Marrow Transplant program.... Read More

Archives by Year